Call for Abstract

徵求投稿摘要

The deadline for abstract submission is March 10, 2026, and the review results will be announced before March 31, 2026.

摘要提交截止日期為 2026 年 3 月 10 日，評審結果將於 2026 年 3 月 31 日前公佈。

Theme

主題

"Cancer and Chronic Disease Screening Aligned with 4P Health"

"癌症與慢性疾病篩檢-與『4P 健康』接軌"

We welcome abstracts related to innovations, evidence, and challenges in cancer and chronic disease screening under the 4P Health framework—Preventive, Predictive, Personalized, and Participatory.

歡迎提交4P健康框架—預防、預測、個人化和參與性之癌症和慢性病篩檢的創新、實證和挑戰等相關的摘要。

4P Health

4P 健康

A. Preventive 預防

• Population-based screening, program performance, policy, and quality management

族群篩檢, 計畫成效, 政策和品質管理

B. Predictive 預測

• AI and data-driven risk modeling, biomarkers, multi-omics, and digital twins

人工智慧和資料構建的風險模型, 生物標記, 多體學和數位雙胞

C. Personalized 個人化

• Risk-stratified screening, genetic and lifestyle factors, precision prevention, ethics

風險分層篩檢, 遺傳和生活型態因素, 精準預防和倫理

D. Participatory 參與性

• Community engagement, health literacy, digital health, behavioral interventions

社區參與、健康素養、數位健康、行為介入

E. Regional and Cross-Cutting Perspectives 區域和跨領域視角

• Comparative studies, system innovations, collaboration across Asia

比較研究、系統創新與合作

Guideline for Submission

投稿須知

• The abstract should be structured.

摘要請採結構式撰寫。

• The length of the abstract should not exceed 300 words excluding author details and headers.

摘要字數 (不含作者資訊與標題) 不超過 300 字。

• Please use Calibri font, size 12.

請使用 Calibri 字型，字體大小 12。

• Please include the full first names and surname names of first author, as well as the names of their affiliation, and countries.

請列出第一作者的英文全名 (名字與姓氏)，並註明其所屬機構名稱及國家。

• It is important to ensure that your abstract is free from spelling, grammatical, and scientific errors.

請確認摘要內容無拼字、文法及科學性錯誤。